Log In
BCIQ
Print this Print this
 

JNJ-63623872

  Manage Alerts
Collapse Summary General Information
Company Johnson & Johnson
DescriptionUndisclosed oral small molecule
Molecular Target Undisclosed
Mechanism of ActionUndisclosed
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationInfluenza virus
Indication DetailsTreat influenza A infection
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today